术前血清碱性磷酸酶水平对胸主动脉腔内修复术后疗效的预测价值
The Predictive Value of Preoperative Serum Alkaline Phosphatase Level for Efficacy after Thoracic Endovascular Aortic Repair
DOI: 10.12677/ACM.2021.1111778, PDF,    科研立项经费支持
作者: 邓 浩, 邓泓博, 池一凡*:青岛大学附属青岛市海慈医院心脏中心,山东 青岛
关键词: 胸主动脉腔内修复术碱性磷酸酶主动脉疾病预测价值Thoracic Endovascular Aortic Repair Serum Alkaline Phosphatase Aortic Disease Predictive Value
摘要: 目的:探讨术前血清碱性磷酸酶(ALP)对胸主动脉腔内修复术(TEVAR)后疗效的预测价值。方法:回顾性分析2013年2月至2019年12月期间在我院接受TEVAR手术患者的临床资料。所有患者根据术前ALP水平,以中位数77.7 U/L为临界值分为低ALP水平组(第一组)和高ALP水平组(第二组)。比较两组患者术后复合事件的发生率,复合事件被定义为TEVAR术后1年内存在以下一种或多种情况:心肌梗死、脑血管意外、需要血液透析、肺部并发症、器官衰竭、感染和死亡,并逐步用Logistic回归分析评价复合事件发生率的预测因素。结果:两组复合事件的发生率分别是28.3%、45.1% (P = 0.002)。第二组ALP水平([OR] 1.393, 95%[CI] 1.049~1.735, P = 0.019)是复合事件发生率的独立预测因素。结论:在接受TEVAR的患者中,术前高ALP水平与不良结局间存在着独立的关系,这可能提示ALP作为危险分层有着潜在的作用。
Abstract: Objective: To explore the predictive value of preoperative serum alkaline phosphatase (ALP) level for efficacy after thoracic endovascular aortic repair (TEVAR). Methods: Clinical data of patients undergoing TEVAR in our hospital from February 2013 to December 2019 were retrospectively analyzed. All patients were divided into low ALP group (group 1) and high ALP group (group 2) according to preoperative ALP level and median 77.7 U/L as the critical value. The incidence of postoperative compound events was compared between the two groups, which were defined as the presence of one or more of the following: myocardial infarction, cerebrovascular accident, need hemodialysis, pulmonary complication, organ failure, infection and mortality within 1 year after TEVAR, and stepwise logistic regression analysis was performed to evaluate the predictors for compound events. Results: The incidence of compound events was 28.3% in group 1, 45.1% in group 2 (P = 0.002). The ALP level ([OR] 1.393, 95%[CI] 1.049~1.735, P = 0.019) in group 2 was an independent predictor of compound events. Conclusion: There is an independent relationship between high preoperative ALP levels and adverse outcomes in patients undergoing TEVAR, which may suggest a potential role of ALP level as a risk stratification.
文章引用:邓浩, 邓泓博, 池一凡. 术前血清碱性磷酸酶水平对胸主动脉腔内修复术后疗效的预测价值[J]. 临床医学进展, 2021, 11(11): 5271-5278. https://doi.org/10.12677/ACM.2021.1111778

参考文献

[1] 薛金熔, 李滨, 刘永民, 白涛, 潘旭东, 刘宁宁, 等. 急性主动脉夹层合并下肢缺血的外科治疗效果[J]. 中华医学杂志, 2017, 97(14): 1093-1095.
[2] Garzon, G., Fernandez-Velilla, M., Marti, M., Acitores, I., Ybáñez, F. and Riera, L. (2005) Endovascular Stent-Graft Treatment of Thoracic Aortic Disease. RadioGraphics, 25, S229-S244. [Google Scholar] [CrossRef] [PubMed]
[3] Haarhaus, M., Brandenburg, V., Kalantar-Zadeh, K., Stenvinkel, P. and Magnusson, P. (2017) Alkaline Phosphatase: A Novel Treatment Target for Cardiovascular Disease in CKD. Nature Reviews Nephrology, 13, 429-442. [Google Scholar] [CrossRef] [PubMed]
[4] Acheampong, D.O., Paul, P., Guerrier, S., Boateng, P. and Leitman, I.M. (2018) Effect of Resident Involvement on Morbidity and Mortality Following Thoracic Endovascular Aortic Repair. Journal of Surgical Education, 75, 1575-1582. [Google Scholar] [CrossRef] [PubMed]
[5] Tsubota, H., Sakaguchi, G. and Marui, A. (2019) Open and Endovascular Thoracic Aortic Repair in Patients with End-Stage Renal Disease. Interactive CardioVascular and Thoracic Surgery, 29, 761-765. [Google Scholar] [CrossRef] [PubMed]
[6] Pohl, S.O., Pervaiz, S., Dharmarajan, A. and Agostino, M. (2019) Gene Expression Analysis of Heat-Shock Proteins and Redox Regulators Reveals Combinatorial Prognostic Markers in Carcinomas of the Gastrointestinal Tract. Redox Biology, 25, Article ID: 101060. [Google Scholar] [CrossRef] [PubMed]
[7] Li, X., Zhang, W., Liu, J., Gonzalez, L., Liu, D., Zhang, L., et al. (2020) Contrast-Induced Kidney Nephropathy in Thoracic Endovascular Aortic Repair: A 2-Year Retrospective Study in 470 Patients. Angiology, 71, 242-248. [Google Scholar] [CrossRef] [PubMed]
[8] Zakko, J., Scali, S., Beck, A.W., Klodell Jr., C.T., Beaver, T.M., Martin, T.D., et al. (2014) Percutaneous Thoracic Endovascular Aortic Repair Is Not Contraindicated in Obese Patients. Journal of Vascular Surgery, 60, 921-928. [Google Scholar] [CrossRef] [PubMed]
[9] Faure, E.M., Canaud, L., Marty-Ane, C., Becquemin, J.P. and Alric, P. (2015) Endovascular Management of Rupture in Acute Type B Aortic Dissections. European Journal of Vascular and Endovascular Surgery, 49, 655-660. [Google Scholar] [CrossRef] [PubMed]
[10] Scali, S.T., Wang, S.K., Feezor, R.J., Huber, T.S., Martin, T.D., Klodell, C.T., et al. (2014) Preoperative Prediction of Spinal Cord Ischemia after Thoracic Endovascular Aortic Repair. Journal of Vascular Surgery, 60, 1481-1490. [Google Scholar] [CrossRef] [PubMed]
[11] Ruan, Z.B., Zhu, L., Yin, Y.G. and Chen, G.-C. (2014) Risk Factors of Early and Late Mortality after Thoracic Endovascular Aortic Repair for Complicated Stanford B Acute Aortic Dissection. Journal of Cardiac Surgery, 29, 501-506. [Google Scholar] [CrossRef] [PubMed]
[12] Zapf, M.A.C., McEvoy, M.D., Brumley, M.T., Hamm, J. and Wanderer, J.P. (2020) Patients Able to Complete an Online Preoperative Screening Tool Are Younger, but Have Similar Comorbid Status and Health Literacy. Journal of Clinical Anesthesia, 64, Article ID: 109802. [Google Scholar] [CrossRef] [PubMed]
[13] Schoppet, M. and Shanahan, C.M. (2008) Role for Alkaline Phosphatase as an Inducer of Vascular Calcification in Renal Failure? Kidney International, 73, 989-991. [Google Scholar] [CrossRef] [PubMed]
[14] Lomashvili, K.A., Garg, P., Narisawa, S., Millan, J.L., O’Neill, W.C. (2008) Upregulation of Alkaline Phosphatase and Pyrophosphate Hydrolysis: Potential Mechanism for Uremic Vascular Calcification. Kidney International, 73, 1024-1030. [Google Scholar] [CrossRef] [PubMed]
[15] Gao, S., Ren, Y., Zhang, H., Pan, B. and Gao, H. (2016) Identification and Expression Analysis of IκB and NF-κB Genes from Cyclina sinensis. Fish & Shellfish Immunology, 56, 427-435. [Google Scholar] [CrossRef] [PubMed]
[16] Lomashvili, K.A., Cobbs, S., Hennigar, R.A., Hardcastle, K. and O’Neill, W.C. (2004) Phosphate-Induced Vascular Calcification: Role of Pyrophosphate and Osteopontin. Journal of the American Society of Nephrology, 15, 1392-1401. [Google Scholar] [CrossRef
[17] Iribarren, C., Sidney, S., Sternfeld, B. and Browner, W.S. (2000) Calcification of the Aortic Arch: Risk Factors and Association with Coronary Heart Disease, Stroke, and Peripheral Vascular Disease. JAMA, 283, 2810-2815. [Google Scholar] [CrossRef] [PubMed]
[18] Oh, P.C., Lee, K., Kim, T.H., Moon, J., Park, H.W., Jang, H.-J., et al. (2017) Prognostic Impact of Alkaline Phosphatase Measured at Time of Presentation in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. PLoS ONE, 12, Article ID: e171914. [Google Scholar] [CrossRef] [PubMed]
[19] Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. and Cook, N.R. (2002) Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events. New England Journal of Medicine, 347, 1557-1565. [Google Scholar] [CrossRef
[20] Kerner, A., Avizohar, O., Sella, R., Bartha, P., Zinder, O., Markiewicz, W., et al. (2005) Association between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 193-197. [Google Scholar] [CrossRef
[21] Beddhu, S., Ma, X., Baird, B., Cheung, A.K. and Greene, T. (2009) Serum Alkaline Phosphatase and Mortality in African Americans with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology, 4, 1805-1810. [Google Scholar] [CrossRef
[22] Abramowitz, M., Muntner, P., Coco, M., Southern, W., Lotwin, I., Hostetter, T.H., et al. (2010) Serum Alkaline Phosphatase and Phosphate and Risk of Mortality and Hospitalization. Clinical Journal of the American Society of Nephrology, 5, 1064-1071. [Google Scholar] [CrossRef
[23] Peters, E., Heemskerk, S., Masereeuw, R. and Pickkers, P. (2014) Alkaline Phosphatase: A Possible Treatment for Sepsis-Associated Acute Kidney Injury in Critically Ill Patients. American Journal of Kidney Diseases, 63, 1038-1048. [Google Scholar] [CrossRef] [PubMed]